Connecting you to content on EBSCOhost

Works by Willemse, Pax H.B.

Results: 5

1

Dose Intensity of Standard Adjuvant CMF with Granulocyte Colony-Stimulating Factor for Premenopausal Patients with Node-Positive Breast Cancer.

Published in:

Oncology, 1996, v. 53, n. 4, p. 289, doi. 10.1159/000227575

By:

de Graaf, Hiltje;
Willemse, Pax H.B.;
Bong, Barbara;
Piersma, Henk;
Tjabbes, Tonnis;
van Veelen, Henk;
Coenen, Jules L.L.M.;
de Vries, Elisabeth G.E.

Publication type:

Article

2

Heat-shock-protein-27(HSP27) expression in ovarian carcinoma: Relation in response to chemotherapy and prognosis.

Published in:

International Journal of Cancer, 1999, v. 84, n. 3, p. 234, doi. 10.1002/(SICI)1097-0215(19990621)84:3<234::AID-IJC6>3.0.CO;2-9

By:

Arts, Henriette J.G.;
Hollema, Harry;
Lemstra, Willy;
Willemse, Pax H.B.;
De Vries, Elisabeth G.E.;
Kampinga, Harm H.;
Van der Zee, Ate G.J.

Publication type:

Article

3

Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer.

Published in:

1992

By:

Gietema, Jourik A.;
Sleijfer, Dirk Th.;
Willemse, Pax H.B.;
Koops, Heimen Schraffordt;
Van Ittersum, Engbertha;
Versechuren, W.M. Monique;
Kromhout, Daan;
Sluiter, Willem J.;
Mulder, Nanno H.;
De Vries, Elisabeth G.E.;
Gietema, J A;
Sleijfer, D T;
Willemse, P H;
Schraffordt Koops, H;
van Ittersum, E;
Verschuren, W M;
Kromhout, D;
Sluiter, W J;
Mulder, N H;
de Vries, E G

Publication type:

journal article

4

Variability in axillary lymph node dissection for breast cancerThis work was performed at the Comprehensive Cancer Center North‐Netherlands.Presented in part at the Annual Meeting of the American Society of Clinical Oncology, Atlanta, 1999.

Published in:

Journal of Surgical Oncology, 2004, v. 87, n. 1, p. 4, doi. 10.1002/jso.20061

By:

Michael Schaapveld;
Renée Otter;
Elisabeth G.E. de Vries;
Vaclav Fidler;
Joris A.K. Grond;
Winette T.A. van der Graaf;
Pieter L. de Vogel;
Pax H.B. Willemse

Publication type:

Article

5

Immunization with a P53 synthetic long peptide vaccine induces P53-specific immune responses in ovarian cancer patients, a phase II trial.

Published in:

International Journal of Cancer, 2009, v. 125, n. 9, p. 2104, doi. 10.1002/ijc.24597

By:

Leffers, Ninke;
Lambeck, Annechien J.A.;
Gooden, Marloes J.M.;
Hoogeboom, Baukje-Nynke;
Wolf, Rinze;
Hamming, Ineke E.;
Hepkema, Bouke G.;
Willemse, Pax H.B.;
Molmans, Barbara H.W.;
Hollema, Harry;
Drijfhout, Jan W.;
Sluiter, Willem J.;
Valentijn, A. Rob P.M.;
Fathers, Loraine M.;
Oostendorp, Jaap;
van der Zee, Ate G.J.;
Melief, Cornelis J.;
van der Burg, Sjoerd H.;
Daemen, Toos;
Nijman, Hans W.

Publication type:

Article